Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
29.75 CNY
-0.83%
Market Closed
Updated:
May 15, 2024
Beijing Hotgen Biotech Co Ltd
Research & Development
|
Beijing Hotgen Biotech Co Ltd
Research & Development Peer Comparison
Comparables:
603259
300759
2269
300347
1548
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Research & Development
-¥124.7m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Research & Development
-¥465m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Research & Development
-¥785.8m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Research & Development
-¥260.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Research & Development
-$432.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Research & Development?
Research & Development
-124.7m
CNY
-124.7m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Research & Development amounts to -124.7m CNY.
What is Beijing Hotgen Biotech Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-48%
-48%
Over the last year, the Research & Development growth was 33%. The average annual Research & Development growth rates for Beijing Hotgen Biotech Co Ltd have been -40% over the past three years , -48% over the past five years .
You don't have any saved screeners yet
